fbpx

molecules of the month

QPX7728

serine and metallo-beta-lactamase inhibitor

oral activity in resistant infection model

from optimization of literature starting point

J. Med. Chem., Apr. 2, 2020

Qpex Biopharma, San Diego, CA

QPX7728
1 min read

QPX7728 is an ultrabroad-spectrum beta-lactamase inhibitor with activity against both serine and zinc metallo-beta-lactamases, in contrast to approved beta-lactamase inhibitors such as relebactam which are only active against serine metalloproteases. Interestingly, the boron of the molecule coordinates to serine hydroxyl groups in serine beta-lactamases, whereas it coordinates as a boronate ligand to the zinc centers of metallo-beta-lactamases.


request a trial

Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.

Request a trial to access insights powering the pros in our industry.


already a member? log in: